Healthcare Services

Cell freezing media market forecast (2026–2030)

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Cell Freezing Media Market From 2026 To 2030?

The cell freezing media market has experienced significant expansion recently. Projections indicate its value will increase from $1.77 billion in 2025 to $1.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this historical growth include the expansion of biobanking activities, the heightened use of cryopreservation in research, the advancement of stem cell research programs, the growing adoption of controlled-rate freezing methods, and the greater availability of liquid nitrogen storage facilities.

The cell freezing media market size is projected to experience substantial expansion over the coming years. It is expected to reach $3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.0%. This anticipated growth during the forecast timeframe is attributed to several factors, including the increasing development of cell and gene therapies, the rising demand for large-scale cell banking, the expansion of personalized medicine research, the growing regulatory requirements for cell storage quality, and the increasing adoption of automated cryopreservation systems. Key trends anticipated during the forecast period encompass the increasing adoption of ready-to-use cryopreservation media, a rising demand for serum-free freezing media, the growing use of GMP-grade cryoprotectants, the expansion of long-term cell banking practices, and an enhanced focus on post-thaw cell recovery.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/global-cell-freezing-media-market-report

Which Strong Drivers Are Impacting The Cell Freezing Media Market Growth?

The increasing need for personalized medicine is anticipated to fuel the expansion of the cell freezing media market in the future. Personalized medicine is a medical strategy where treatments are customized for individual patients, considering their genetic, environmental, and lifestyle elements to enhance results and patient care. The demand for this approach is escalating, driven by progress in genomic technologies that facilitate accurate identification of genetic differences and the development of specific treatments for individuals. Cell freezing media plays a crucial role in advancing personalized medicine by offering dependable cryopreservation solutions that safeguard patient-specific cells, tissues, and various biologics. This ensures high viability and functionality after thawing, thereby supporting the creation of customized therapies and leading to better treatment outcomes. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable rise from the 12 approved in 2022. Consequently, the increasing need for personalized medicine is indeed propelling the expansion of the cell freezing media market.

How Is The Cell Freezing Media Market Organized By Segment Classification?

The cell freezing media market covered in this report is segmented –

1) By Type: Dimethyl Sulfoxide (DMSO), Glycerol, Sucrose, Ficoll, Serum-Based Media

2) By Cell Culture Type: Suspension Cell Culture, 2D Cell Culture, 3D Cell Culture, Other Cell Culture Types

3) By Distribution Channel: Direct Sales, Distributors, E-Commerce Platforms, Retail Outlets, Specialized Scientific Instrumentation Suppliers

4) By Application: Stem Cell Research, Embryonic Cell Preservation, Hematopoietic Cell Preservation, Tissue Sample Storage, Gene Therapy Applications

5) By End-User: Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Clinical Laboratories, Contract Research Organizations (CROs)

Subsegments:

1) By Dimethyl Sulfoxide (DMSO): Pharmaceutical Grade Dimethyl Sulfoxide, Laboratory Grade Dimethyl Sulfoxide, Industrial Grade Dimethyl Sulfoxide, High Purity Dimethyl Sulfoxide

2) By Glycerol: Pharmaceutical Grade Glycerol, Analytical Grade Glycerol, Biological Grade Glycerol, Synthetic Grade Glycerol

3) By Sucrose: Pharmaceutical Grade Sucrose, Analytical Grade Sucrose, Biological Grade Sucrose, Crystalline Sucrose

4) By Ficoll: Ficoll 400, Ficoll 70, Ficoll PM 400 Solution, Low Viscosity Ficoll

5) By Serum-Based Media: Fetal Bovine Serum Based Media, Human Serum Based Media, Horse Serum Based Media, Newborn Calf Serum Based Media

Which Trends Are Contributing To Changes In The Cell Freezing Media Market?

Leading companies operating in the cell freezing media market are focusing on developing advanced products, such as specialized cryopreservation media, to boost efficiency, enhance cell viability, and accelerate therapeutic development. Specialized cryopreservation media refer to formulated solutions designed to preserve cells, tissues, or biological materials at very low temperatures while maintaining their viability, functionality, and structural integrity. For instance, in April 2024, Pluristyx Inc., a US-based biotechnology company, launched PluriFreeze. It is a xeno-free and serum-free cGMP-manufactured media designed to improve post-thaw recovery and function of a wide range of cell types, including stem cells and immune cells. It is engineered to provide a robust, ready-to-use formulation that ensures high cell viability and functionality, supporting the transition of therapies from research to clinical application. PluriFreeze improves post-thaw cell viability, manufacturing efficiency, and reproducibility in stem cell and cell therapy development processes.

Who Are The Industry Participants Involved In The Cell Freezing Media Market?

Major companies operating in the cell freezing media market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, FUJIFILM Corporation, Lonza Group Ltd., Avantor Inc., Sartorius AG, BioRad Laboratories Inc., BioTechne Corporation, Miltenyi Biotec GmbH, Stemcell Technologies Inc., Vitrolife AB, American Type Culture Collection (ATCC), Bio-Life Solutions Inc., Nacalai Tesque Inc., PromoCell GmbH, Nippon Genetics Co. Ltd., Nippon Zenyaku Kogyo Co. Ltd., Quality Biological Inc., Corning Incorporated

Get The Full Cell Freezing Media Market Report:

https://www.thebusinessresearchcompany.com/report/global-cell-freezing-media-market-report

Where Is The Cell Freezing Media Market Primarily Concentrated By Region?

North America was the largest region in the cell freezing media market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell freezing media market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Freezing Media Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-cell-freezing-media-market-report

Browse Through More Reports Similar to the Global Cell Freezing Media Market 2026, By The Business Research Company

Frozen Storage Market Report 2026

https://www.thebusinessresearchcompany.com/report/frozen-storage-global-market-report

Cell Cryopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cryopreservation-global-market-report

Freeze Drying Market Report 2026

https://www.thebusinessresearchcompany.com/report/freeze-drying-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795